Life sciences service provider EVERSANA has named industry veteran Mike Guarino to lead its global health agency EVERSANA INTOUCH.
NICE backs stomach cancer, PAH drugs for NHS use
AZ’s Imfinzi is the first NHS immunotherapy for a form of stomach cancer, while MSD’s Winrevair gets a green light for rare respiratory disease PAH.


